Product Description

Betahistine Dihydrochloride IP 16 mg is a pharmaceutical formulation developed for the effective management of vertigo, dizziness, and balance-related disorders under medical supervision. The formulation is commonly prescribed to help relieve symptoms associated with inner ear conditions, including Ménière’s disease and vestibular disorders, which may affect balance, hearing, and overall quality of life.

Vertigo and balance disorders can significantly interfere with daily activities and may present with symptoms such as dizziness, spinning sensations, loss of balance, nausea, ringing in the ears (tinnitus), and hearing disturbances. Effective management of these symptoms is essential to improve patient comfort, mobility, and overall well-being.

Betahistine Dihydrochloride works by improving blood circulation within the inner ear and reducing pressure in the vestibular system. This action helps regulate the balance mechanisms of the inner ear, supporting symptom relief and improved vestibular function. By enhancing blood flow and reducing inner ear fluid pressure, Betahistine helps decrease the frequency and severity of vertigo episodes.

The formulation is widely used as part of long-term management programs for vestibular disorders and may help improve balance control, reduce dizziness, and support overall ear health. Consistent use under medical supervision can contribute to better symptom control and improved quality of life.

Manufactured under stringent WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical technologies and undergoes comprehensive quality testing to ensure safety, efficacy, purity, and pharmaceutical consistency. Every batch is carefully monitored to maintain dependable therapeutic performance and high-quality healthcare standards.

Key Features

• Supports management of vertigo and dizziness
• Helps improve balance and vestibular function
• Assists in managing Ménière’s disease symptoms
• Supports inner ear circulation and function
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards
• Produced using advanced pharmaceutical processes

Uses

• Vertigo management
• Ménière’s disease symptom relief
• Dizziness and balance disorder support
• Vestibular function management under medical supervision

How It Works

Betahistine Dihydrochloride works by improving blood flow within the inner ear and helping reduce pressure in the vestibular system. This action supports balance regulation and helps reduce symptoms such as dizziness, vertigo, and tinnitus.

Possible Side Effects

Common side effects may include:

• Headache
• Nausea
• Indigestion
• Mild stomach discomfort
• Bloating
• Dizziness

Patients should seek immediate medical attention if severe allergic reactions, breathing difficulties, or unusual symptoms occur.

Precautions

• Use only under medical supervision
• Inform your doctor about asthma, stomach ulcers, or other medical conditions
• Avoid overdose or self-medication
• Follow the prescribed dosage carefully
• Pregnant or breastfeeding women should consult a healthcare professional before use

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, the formulation undergoes stringent quality control procedures and comprehensive testing to ensure safety, efficacy, purity, and dependable therapeutic performance. Each batch is evaluated according to international pharmaceutical standards to maintain consistent quality and reliable patient outcomes.